Sridevi Colten

Sridevi Colten is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as the Director of Global Neurology & Immunology Strategic Insights at EMD Serono, Inc. since December 2021. Prior to this role, Sridevi was the Director of Business Analytics at Oncopeptides, Inc. and held various leadership positions at Sunovion Pharmaceuticals, including Director of Commercial Insights, where Sridevi was instrumental in the US launch of KYNMOBI® for Parkinson's Disease. Sridevi's extensive experience also includes significant roles at Momenta Pharmaceuticals, IPSEN, Decision Resources, Vertex Pharmaceuticals, and Harvard Medical School. Sridevi holds an MBA from Babson F.W. Olin Graduate School of Business and a BS in Biochemistry from Rutgers University.